Phase 2Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Sponsor
- Retension Pharmaceuticals. Inc. (Industry)
- Enrolment
- 280 planned
- Conditions
- Uncontrolled Hypertension
- Interventions
- RTN-001; Matching placebo control
- Ages
- adults, older adults
- Registry
- NCT07142356
Full record on ClinicalTrials.gov
From the registry
The purpose of this clinical trial is to measure the safety and efficacy of RTN-001 in adult participants with uncontrolled hypertension versus placebo.
Primary outcomes
- Mean change in systolic blood pressure (SBP) at 4 weeks
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered